Skip to main content
Premium Trial:

Request an Annual Quote

University of Sydney Wins A$1.4M Grant, Teams With Allelica on Cardiac Polygenic Risk Scores

NEW YORK – Researchers at the University of Sydney said Monday that they have won a grant worth A$1.4 million ($1.1 million) from Australia's National Health and Medical Research Council?and will work with Allelica to apply polygenic risk scores for coronary artery disease prevention.

The grant money supplements the A$2 million that project leaders have received from industry partners, according to the university.

With the funding, a multidisciplinary team led by Gemma Figtree, chair of the University of Sydney's Cardiovascular Initiative, will develop strategies to prevent heart disease by applying polygenic risk scores in primary care settings.

Figtree and colleagues will test and validate Allelica's polygenic risk score technology in clinical practice, with hopes of integrating the scores into routine clinical practice, a stated goal of New York-based Allelica. Participants in the study will receive their results back through the Allelica platform.

"The first step in reducing the impact of preventable chronic disease is to identify people at high risk," Allelica CEO Giordano Bottà said in a statement. "In the case of coronary artery disease, the root of the problem is the dangerous lack of accuracy in most risk classification models."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.